Published in Women's Health Weekly, May 16th, 2002
Several studies have introduced the idea of treating fetuses in utero using somatic gene transfer. Yet, limitations and complications affecting the efficacy of such therapy are still unknown. D. Gallot and coauthors in the Laboratory for Molecular Oncology at the Centre Jean-Perrin in Clermont-Ferrand, France, announced the goal of their research "was to assess the integration and transcription of a proviral marker gene injected intraperitoneally into rat fetuses as...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly